$4.69
-0.15 (-3.10%)
DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA)
CAPS Rating:
A dermatology company, which is engaged in the development and marketing Levulan photodynamic therapy and other products for common skin conditions.
RSS Headlines
Fool UK